Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiongdan Wan in Major Depressive Disorder
NCT05136365Phase 2Completed
- Sponsor
- Shanghai Mental Health Center
- Start
- Dec 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xiongdan wan in major depressive disorder (MDD), sponsored by Shanghai Mental Health Center. Started Dec 2021; status: completed.
02
Drugs
xiongdan wan
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05136365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05136365.